You just read:

Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease

News provided by

Ionis Pharmaceuticals, Inc.

Jan 05, 2016, 07:00 ET